X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (124) 124
Book Review (18) 18
Publication (13) 13
Conference Proceeding (8) 8
Patent (6) 6
Web Resource (3) 3
Book / eBook (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (82) 82
index medicus (79) 79
oncology (61) 61
female (59) 59
middle aged (31) 31
breast neoplasms - drug therapy (30) 30
adult (25) 25
aged (25) 25
breast cancer (25) 25
cancer (22) 22
chemotherapy (21) 21
breast neoplasms - pathology (20) 20
trastuzumab (19) 19
animals (17) 17
prognosis (17) 17
antineoplastic agents - therapeutic use (16) 16
breast neoplasms - genetics (16) 16
treatment outcome (15) 15
male (13) 13
therapy (13) 13
antineoplastic agents - pharmacology (11) 11
breast neoplasms - mortality (11) 11
drug therapy (11) 11
abridged index medicus (10) 10
antibodies, monoclonal, humanized (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
article (10) 10
disease-free survival (10) 10
drug evaluation (10) 10
gene expression regulation, neoplastic (10) 10
genetic aspects (10) 10
mice (10) 10
drug administration schedule (9) 9
follow-up studies (9) 9
neoplasm staging (9) 9
neoplasms - drug therapy (9) 9
receptor, erbb-2 - metabolism (9) 9
survival analysis (9) 9
antineoplastic agents - adverse effects (8) 8
biomarkers, tumor - genetics (8) 8
biomarkers, tumor - metabolism (8) 8
expression (8) 8
immunohistochemistry (8) 8
monoclonal-antibody (8) 8
mutation (8) 8
pharmacology & pharmacy (8) 8
research (8) 8
tumors (8) 8
amplification (7) 7
antibodies, monoclonal - therapeutic use (7) 7
biomarkers, tumor - analysis (7) 7
breast (7) 7
breast neoplasms - therapy (7) 7
chemistry (7) 7
genes (7) 7
genetics (7) 7
neoplasm metastasis (7) 7
patients (7) 7
receptor, erbb-2 - analysis (7) 7
survival (7) 7
tamoxifen (7) 7
adjuvant chemotherapy (6) 6
aged, 80 and over (6) 6
breast neoplasms - chemistry (6) 6
breast neoplasms - metabolism (6) 6
chemotherapy, adjuvant (6) 6
clinical trials (6) 6
clinical trials as topic (6) 6
health aspects (6) 6
kinetics (6) 6
medicine & public health (6) 6
open-label (6) 6
phase-ii (6) 6
tumor cells, cultured (6) 6
acyclic or carbocyclic compounds (5) 5
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (5) 5
alterations (5) 5
antibodies, monoclonal - administration & dosage (5) 5
antibodies, monoclonal - adverse effects (5) 5
antineoplastic agents - administration & dosage (5) 5
biomarkers (5) 5
breast neoplasms - blood (5) 5
breast neoplasms - diagnosis (5) 5
breast-cancer (5) 5
cancer therapies (5) 5
care and treatment (5) 5
cell line, tumor (5) 5
cells (5) 5
cohort studies (5) 5
efficacy (5) 5
gene-expression (5) 5
her2 (5) 5
human necessities (5) 5
hygiene (5) 5
kaplan-meier estimate (5) 5
medical or veterinary science (5) 5
medical research (5) 5
medicine (5) 5
medicine, general & internal (5) 5
metallurgy (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 4605 - 4605
Journal Article
Neoplasia (United States), ISSN 1522-8002, 2014, Volume 16, Issue 4, pp. 375 - 375
[This corrects the article DOI: 10.1593/neo.131694.]. 
Journal Article
Neoplasia (New York, N.Y.), ISSN 1522-8002, 1/2014, Volume 16, Issue 1, pp. 43 - 72
Phosphoinositide 3-kinase (PI3K) pathway, in addition to its pro-proliferative and antiapoptotic effects on tumor cells, contributes to DNA damage repair... 
Journal Article
BMC Cancer, ISSN 1471-2407, 11/2013, Volume 13, Issue 1, pp. 537 - 537
Background: Triple Negative subset of (TN) Breast Cancers (BC), a close associate of the basal-like subtype (with limited discordance) is an aggressive form of... 
Breast cancer | Microarray | Wnt | FFPE | Triple negative | GENE-EXPRESSION SIGNATURE | ANDROGEN RECEPTOR | REGULATES EXPRESSION | SUBTYPES | T-CELL-FACTOR | BETA-CATENIN | MESENCHYMAL TRANSITION | ONCOLOGY | PATHWAY | COLORECTAL-CANCER | BASAL | RNA, Small Interfering - genetics | Cell Proliferation | Prognosis | Follow-Up Studies | Oligonucleotide Array Sequence Analysis | Humans | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Gene Expression Profiling | Wnt Proteins - metabolism | Brain Neoplasms - metabolism | Immunoenzyme Techniques | Bone Neoplasms - metabolism | Neoplasm Recurrence, Local - pathology | Paraffin Embedding | Brain Neoplasms - secondary | Wnt Proteins - genetics | Lung Neoplasms - secondary | Triple Negative Breast Neoplasms - pathology | Biomarkers, Tumor - metabolism | Female | Bone Neoplasms - genetics | Tumor Cells, Cultured | Real-Time Polymerase Chain Reaction | Lung Neoplasms - genetics | Neoplasm Recurrence, Local - metabolism | Signal Transduction | RNA, Messenger - genetics | Brain Neoplasms - genetics | Survival Rate | Reverse Transcriptase Polymerase Chain Reaction | beta Catenin - metabolism | Blotting, Western | beta Catenin - genetics | Triple Negative Breast Neoplasms - genetics | Triple Negative Breast Neoplasms - metabolism | beta Catenin - antagonists & inhibitors | Neoplasm Recurrence, Local - genetics | Biomarkers, Tumor - genetics | Neoplasm Staging | Cell Movement | Cohort Studies | Research | Metastasis | Biological markers | Analysis | Oncology, Experimental | Cancer | Index Medicus
Journal Article
Journal Article
Current Drug Targets, ISSN 1389-4501, 2012, Volume 13, Issue 12, pp. 1510 - 1524
Journal Article
Journal Article
Journal Article
Meta Gene, ISSN 2214-5400, 06/2015, Volume 4, pp. 129 - 141
Triple negative (TN) breast cancers which lack expression of the estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2) receptors convey... 
GSEA | Breast cancer | NR6A1 | Triple negative | ER
Journal Article
Journal Article
The American Journal of Pathology, ISSN 0002-9440, 07/1999, Volume 155, Issue 1, p. 77
  During the past several years, a panel of human tumor cell lines (predominantly ovarian) with acquired resistance to cisplatin, the orally bioavailable... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.